Computerized cyclic voltammetric detection
after HPLC of the antineoplastic agents
etoposide, teniposide, adriamycin and its
metabolite adriamycinol in urine samples by Ploegmakers, H. H. J. L. et al.
Journal of Automatic Chemistry Vol. 11, No. 3 (May-June 1989), pp. 106-112
Computerized cyclic voltammetric detection
after HPLC of the antineoplastic agents
etoposide, teniposide, adriamycin and its
metabolite adriamycinol in urine samples
H. H. J. L. Ploegmakers and P. A. Moritz
Department ofAnalytical Pharmacy, State University of Utrecht, Catharijnesingel
60, 3511 GH Utrecht, The Netherlands
P.J.M.M. Toll
Groot Zie/engasthuis Hospital, Nieuwstraat 34, 5211 NL’s-Hertogenbosch, The
Netherlands
and W. J. van Oort
Department ofAnalytical Pharmacy, State University of Utrecht, Catharijnesingel
60, 3511 GH Utrecht, The Netherlands
A computerized electrochemical detection system for application
after HPLC, provided with a cyclic voltammetric oxidative and
reductive module, is describedfor the on-line qualitative determina-
tion of electroactive antineoplastic agents and metabolites in urine
samples, collected from cancer patients, following intravenous
administration.
The application of two cyclic voltammetric detection modes
provides an insight into both oxidative and reductive electrode
reactions of compounds, passing the detector and the occurrence of
(it)reversible chemical and electrochemicalprocesses at the electrode
suace. In this way, redox properties of drugs and metabolites
characteristic oftheir molecular structure, can be established, which
may provide information related lo their (enzymatic) bioactivation.
In the cyclic voltammetric mode, the system permits automatic
detection ofa compound in the cell, recording, storage andplotting
of voltammograms and calculation of the retention times, the
half-wave potentials and the peak potentials of each scan of all
indivi((ual compounds. For routine use, storage of 68 voltammo-
grams on-line is sufcientfor the analysis ofbiological samples in
clinical-pharmacological research. Special attention has been paid
to automatic, multi-reference-point component detection.
Based on their concentrations in urine, the oxidative cyclic
voltammetric mode, using a glassy carbon electrode, permits the
determination of etoposide and teniposide, whereas the reductive
cyclic voltammetric mode, with a static mercury drop electrode,
permits the determination of adriamycin and its metabolite
adriamycinol.
Introduction
For on-line detection after high-performance liquid
chromatography (HPLC), many methods of analysis are
available, based on various physicochemical principles
such as UV and fluorescence spectrometry and amper-
ometry. In general, all these modes of detection are able
to provide quantitative information for suitable com-
pounds. Selectivity can be improved both by optimizing
the chromatographic system and by selecting the opti-
mum wavelength(s) or potential of the detection system
used. Both parameters are determined by the molecular
structure of the compound(s) to be analysed and by the
kind and amounts of interfering compounds in the
sample.
When qualitative information is needed, more sophisti-
cated methods are required such as scanning UV
spectrometry or cyclic voltammetry. Such systems can
provide considerable amounts of qualitative information
about the compounds passing the detector. In practice,
large information streams resulting from such complex
measuring techniques mostly require the application of a
computer.
In a previous paper [1], we described such a com-
puterized cyclic voltammetric detection system in HPLC.
Owing to the large background current, which is inherent
in cyclic voltammetry using a glassy carbon electrode, the
detection limit for quantitative analysis proved to be
higher than that of voltammetric detection systems,
applied at constant potential. Nevertheless, that investi-
gation showed that significantly more qualitative infor-
mation about compounds can be achieved by cyclic
voltammetric detection than voltammetric constant
potential detection.
The relatively high detection limit ofsuch a computerized
cyclic voltammetric system has hampered the qualitative
analysis of low-dosage drugs and metabolites in plasma
and serum up to now 1, 2]. However, the volume ofurine
samples is rarely limited. The analysis of parent drugs
and possible metabolite(s) in urine, a major elimination
route of drugs, may yield information on the kinetics and
metabolism.
To show the performance of the technique, we selected
the anticancer drugs etoposide, teniposide and adriamy-
cin as model compounds. In biological samples, e.g.,
urine from patients following intravenous administration,
such compounds are always accompanied by several
interfering oxidizable and reducible endogenous com-
pounds. These cytostatic compounds are also believed to
possess an extended metabolism pattern, creating the
need for increased qualitative information, applying
relatively simple technology if possible.
As most of these drugs need enzymatic oxidative or
reductive bioactivation, producing, e.g., relatively stable
free radicals, fast-scanning electrochemical detection
modes may provide other or additional information about
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the reaction mechanisms compared with scanning UV
spectrometry.
Etoposide (VP 16-213) and teniposide (VM 26) are
epipodophyllotoxin derivatives (Podophyllum peltatum L.
and Podophyllum emodi Wallich), active against several
types of tumours, particularly small cell carcinoma of the
lung, adenocarcinoma, ovarian cancer and squamous cell
cancer.
Etoposide and teniposide are known to be excreted in the
urine in the form of the unchanged parent drug and the
hydroxy acid derivative metabolite [3]. Both compounds
differ significantly in concentration, polarity and lipophi-
licity.
For the determination of etoposide and teniposide,
several HPLC systems have been reported, mostly using
UV [4-8] and fluorescence detection [9, 10]. For the
determination of the hydroxy acid metabolite, a method
involving fluorescence detection was described by Strife
et al. [4].
As etoposide and teniposide possess a phenolic hydroxy
group, oxidative electrochemical detection is also applic-
able [11-14]. A routinely applicable method for the
determination of the hydroxy acid metabolites of both
drugs using amperometric detection has been described
by Sinkule and Evans [12]. Holthuis [3] concluded that
the quantitative HPLC of etoposide, using oxidative
amperometry, provides more sensitive detection (absol-
ute detection limit 250 pg) than UV (detection limit
100-500 ng/ml in plasma) and fluorescence methods
(detection limit 50 ng/ml in plasma).
Adriamycin, an anthracycline antibiotic produced by
Streptomyces species, is active and frequently used against
leukaemias and mammary carcinomas. It is excreted in
the urine in the form of the unchanged drug and its
metabolite adriamycinol, the 13-hydroxy derivative of
adriamycin.
Experimental
Hardware
The heart of the on-line pilot voltage-generating and
data-acquisition system used is an Apple IIe computer
(figure 1), equipped with 64 kbytes ofon-board RAM and
two 125K Apple floppy disk drives. We combined this
computer with an Axlon 320K Ramdisk, a 12-bit,
16-channel Digilog A/D converter, a 12-bit D/A con-
verter (made by coupling a California Computer Systems
7720 parallel interface and an Analog Devices AD
DAC80 D/A converter), a California Computer Systems
Model 7424 real-time clock, an Itoh 8510 parallel printer
with screen-dump facility (Kronemuis APL 13 graphic
printer interface) and a Hewlett-Packard 7470A serial
plotter.
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Figure 1. Schematic diagram of the chromatographic, electro-
chemical and computer system.
Several HPLC systems for the analysis of anthracyclines
have been published using UV 15-19] and fluorescence
detection [20-26]. Anthracyclines possess both phenolic
hydroxy groups, permitting oxidative electrochemical
detection [27, 28], and a p-quinoid system, permitting
reductive electrochemical detection. Application of the
latter method avoids interference from catecholamines
during detection.
So far, no investigations on the analysis of these
compounds using HPLC with electrochemical detection,
exploiting its reductive properties, appear to have been
published; this may offer promising opportunities for
qualitative analysis. This investigation, using relatively
well known drugs and metabolites as model compounds,
was aimed at demonstrating the applicability and re-
liability of computerized scanning electrochemical de-
tection, in the oxidative and reductive mode, with real
biological samples collected from cancer patients.
To this computer system, a Metrohm 641 VA-Detector
potentiostat (output V full-scale), a Princeton Applied
Research 310 polarographic detector for reductive detec-
tion or a laboratory made, centrally injected, electro-
chemical cell for oxidative detection are connected.
The laboratory-made cell consists ofa mini glassy carbon
electrode (GCE) (Metrohm EA-286/1, diameter 3 mm),
placed in the centre of a stainless-steel ring auxiliary
electrode. The distance between the GCE and the jet can
be adjusted by a micrometer on which the electrode is
mounted. The eluent stream is directed perpendicularly
to the surface of the GCE. A laboratory-made Ag/AgC1
reference electrode with a Vycor glass-tipped jacket is
placed close to the working and auxiliary electrodes. The
diameter of the outlet jet of the eluent of the chromato-
graphic system is 0’11 mm. The cell is submerged in a
vessel containing the mobile phase.
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Table 1. Functions of the programs.
Language Program name Function
BASIC HPLC
Assembly CLOCK
Assembly HPLC/ML
BASIC PARAMETER
Assembly DUMMY
Assembly THRESHOLD
Assembly
BASIC
DETERMINATION
CALCULATION
HPLC with electrochemical detection at constant
potential
To reset and restart real-time clock and data storage
in HPLC/ML
Measuring, data storage, timing and drop dislodging
Parameters for cyclic voltammetry
To stabilize SMDE or GCE
Detection ofthe passage ofa compound through
the detector
To store a cyclic voltammogram ofa compound
Display ofvoltammograms on screen and production
ofa paper copy; to filter data and to calculate
peak potential and ’half-wave potential’
The chromatographic system consists of a Model 510
solvent delivery system and a Model UdK septumless
injector (both from Waters Associates). The chromato-
graphic columns and mobile phases used depended on
the compounds being investigated.
Software and interfacing
To control the mercury drop knocker and the nitrogen
stream in the polarographic detector by the computer,
interfacing was achieved by connecting annunciator
outputs of the Apple computer to the rear side connector
J of the Princeton Applied Research 310 polarographic
detector.
In order to detect the moment of injection, the switch in
the chromatographic injector was connected to an input
on the game-connector of the Apple computer by means
of a 74LS00 flip-flop: if the content of address $C061
(hexadecimal) changes from $FF (hexadecimal) to $7F
(hexadecimal), this indicates that an injection has been
made.
As the potentiostat attenuates the pilot voltage ten times,
the D/A converter signal has to be amplified (gain: +10
and -10), enabling the desired potential of the glassy
carbon and mercury working electrodes to be set. To
adapt the input signal to the voltage range of the A/D
converter, the i/E converter of the potentiostat was
connected to the A/D converter by an amplifier/attenua-
tor/offset circuit.
HPLC (Table 1) is a program for performing HPLC with
oxidative or reductive electrochemical detection at con-
stant potential at the GCE and the static mercury
electrode. It deaerates the mobile phase in the detector
cell for 10 min, investigates the number of components
present in the sample and establishes the retention times
of these substances.
On switching on the detector cell, the current is usually
out of range (overload) owing to stabilizing processes at
the electrode surface. Therefore, the CLOCK program, a
subroutine of the HPLC/ML program, permits resetting
and restarting of the real-time clock, the data storage and
the high-resolution graphics screen after a stabilizing
period without losing the variables.
Applying the PAR 310 detector each time a new drop is
dispensed, the volume ofthe drop reaches its final volume
very fast and, shortly afterwards, the capacity current
reaches its minimum value. Therefore, by inserting a
software delay of s after dispensing the mercury drop,
the current can reach a constant value, almost freed from
capacity current. After this delay, 16 current measure-
ments are executed and averaged, using a machine
language routine. The result is stored in the memory and
plotted on screen in the high-resolution graphics mode.
The continuous flow of the eluent against the fragile
mercury drop sometimes blows the drop off the capillary,
resulting into a sudden current cut-off. The frequency of
this process proved to be influenced by the flow-rate, the
composition of the mobile phase and the potential of the
working electrode.
The computer can be used to compensate for this event.
In the HPLC program, all stored current values are
compared with the preceding current measurement; ifthe
difference is less than a user-defined value, then a current
cut-off is detected and this current value is discarded and
replaced by its predecessor; in this way, the curve is
partially smoothed.
The HPLC program also allows the saving of data in
addition to parameters on disk, smoothing the chromato-
gram, using a machine language 11-point parabolic filter
routine, plotting the curves, calculating the retention
times and plotting this information in combination with
the peaks.
In a previous paper [1], a cyclic voltammetric detection
system after HPLC was described in which a GCE was
used. The on-line cyclic voltammograms ofetoposide and
teniposide obtained in this way show waves. To detect a
compound in the electrochemical cell in this system, it is
sufficient to compare the current at a certain potential
(e.g., +700 mV) with the corresponding current
measurement of the blank scan; if the current value is
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higher then the corresponding blank value, increased
with a user-defined threshold, this indicates a compound
passing the detector.
The on-line cyclic voltammograms of adriamycin and
adriamycinol obtained using the static mercury drop
electrode show peaks, however. In this event, the current
decreases at the end of the scan. Therefore, a current
comparison at a single potential value at the end of
each scan is not sufficient. After stabilizing the system,
using six dummy scans (DUMMY program), the
THRESHOLD program is executed. After storage of a
blank scan, each hundredth current measurement is
increased with a user-defined threshold value and stored
in the memory. On scanning, each 100th current
measurement is compared with the corresponding stored
blank current value. If a current measurement is larger,
this indicates that a compound is passing the detector and
then a detection flag is set. After completion of the scan,
the computer checks the flag and, if set, the program
jumps to the storage DETERMINATION subroutine.
This subroutine stores the scan, accompanied with real
time, in the Ramdisk. After completing this subroutine,
the program returns to the THRESHOLD scanning and
comparison mode.
As the voltammograms ofthe parent drugs and decompo-
sition products show both waves and peaks, the CALCU-
LATION program is adapted with a half-wave potential
and a peak potential calculation routine. When applying
the CALCULATION half-wave potential or peak poten-
tial calculation subroutine, it is necessary to smooth the
curve first. In a previous study [1], a parabolic filter
method, written in Applesoft BASIC, was applied. The
software of this method can easily be programmed but it
is time consuming. Because of the favourable data
handling obtained in this way, a 6502 machine language
1-point parabolic filter program was written. This
program filters the data very quickly in the calculations.
Etoposide
Etoposide (VP 16-213) was kindly supplied by Bristol-
Myers Nederland (Bussum, The Netherlands). The
mobile phase consists of methanol- 0"020 M phosphate
buffer (pH 7) (45:55, w/w); the samples are injected on
to a LiChrosorb RP-18 (10 btm) analytical column (30cm
x 3"9 mm i.d.). As a reference solution, etoposide is
dissolved in methanol (analytical-reagent grade, Merck)
at a concentration of 4"796 mg in 10 ml. Under these
conditions, the retention time of etoposide is 7 min 26 s.
Teniposide
Teniposide (VM-26) was kindly supplied by Bristol-
Myers Nederland. The mobile phase consists of
methanol- 0"02 M phosphate buffer (pH 7) (55:45 w/w);
the samples are injected on to the same column as for
etoposide. As a reference solution, teniposide is dissolved
in methanol at a concentration of 5"852 mg in 10 ml.
Under these conditions the retention time of teniposide is
7 min 8 s.
Sample treatment
To determine teniposide in human urine, 50 ml of urine,
after mixing with 5 ml of 0" phosphate buffer (pH 7"3),
are extracted twice with 50 ml ofDCE [3]. The organic
layer is removed and evaporated under nitrogen at 30 C.
The residue is dissolved by sonication in 1’00 ml of
methanol. For determinations in the cyclic voltammetric
mode, an aliquot of 25 bl is injected.
Adriamycin and adriamycinol
Adriamycin hydrochloride and adriamycinol were kindly
supplied by Carlo Erba (Milan, Italy). The mobile phase
consists of methanol-0"02 phosphate buffer (pH 4"2)
(40:60 w/w); the samples are injected on to a LiChrosorb
RP-8 (50432 Ca) (5 m) reversed-phase column (12"5 cm
x 4 mm i.d.). As references, methanolic solutions of
adriamycin (0.497 mg/ml) and adriamycinol (0"438
mg/ml) are used. Under these conditions, the retention
times of adriamycinol and adriamycin are 6 min 4 s and
7 min 32 s, respectively.
Sample treatment
Several methods for the extraction of adriamycin and its
main metabolite adriamycinol have been described.
Some of these methods include liquid-liquid extraction
[20-24] and adsorption chrornatography using a Celite
column [25], a loop column [27] or a syringe cartridge
[26]. As the concentrations of the drug and its metabolite
in urine are low in relation to the sensitivity of cyclic
voltammetric detection, it is necessary to. extract a
relatively large volume of urine.
To concentrate adriamycin and adriamycinol, 60 ml of
human urine [buffered by 5 ml 0"1 phosphate buffer
(pH 8"0)] are extracted twice with 100 ml of chloroform-
methanol (9: 1) [23]. After evaporating the organic phase
under a stream of nitrogen at 30C, the residue is
dissolved in 150 bl of methanol. For determination in the
cyclic voltammetric mode, 100 btl of the methanolic
solution are injected.
Sample treatment
To determine etoposide in human urine, 25 ml of urine,
after mixing with 2"5 ml of 0"1 phosphate buffer (pH
7"3), are extracted twice with 25 ml of 1,2-dichloroethane
(DCE) [13]. The organic layer is removed and evapor-
ated under a stream of nitrogen at 30 C. The residue is
dissolved by sonication in 1"00 ml of methanol. For
determinations in the cyclic voltammetric mode, an
aliquot of 10 btl is injected.
Results and discussion
Etoposide
In on-line experiments, the anodic (forward) scan of the
cyclic voltammogram of etoposide, present in the urine
extract, shows two waves (figure 2). This behaviour is
similar to that of the pure compound ]. The ’half-wave
potentials’ of these waves are +383 mV (n 5, SD
5 mV) and + 722 mV (n 5, SD 3 mV). As the limiting
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Figure 2. On-line cyclic vo/tammogram ofetoposide (VP 16-213)
in a urine extract after HPLC separation. Conditions: 10 l
injected; current range, 0"5 A full-scale; flow-rate, 1 ml/min;
scan speed, 300 m V/s; mobile phase, methanol-O’020 M
phosphate buffer (pH 7) (45:55 w/w); column, LiChrosorb
RP-18.
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Figure 3. On-line cyclic voltammogram ofteniposide (VM-26) in
a urine extract afterHPLC separation. Conditions: 25l injected;
current range, 0"5A full-scale; flow-rate, I ml/min; scan speed,
300 m V/s; mobile phase, methanol- 0"020 M phosphate buffer
(pH 7) (55:45 w/w); column, LiChrosorb RP-18.
current in flow systems is expected to be governed both by
diffusion and by convection, the terms ’Ell‘)’ or ’half-wave
potential’, in quotation marks, have been used, to be
distinguished from the conventional half-wave potential,
El known from classical d.c. polarography [29].
Teniposide
In on-line experiments, the anodic (forward) scan of the
cyclic voltammogram of teniposide, present in the urine
extract, shows two waves (figure 3). This behaviour is
similar to that of the pure compound ]. The ’half-wave
potentials’ are +300 mV (n 5, SD 2 mV) and
+584 mV (n 5, SD 12 mV).
Adriamycin and adriamycinol
For the HPLC of adriamycin, several workers have used
an acetonitrile-containing mobile phase [20, 21, 25-27].
In the electrochemical system described, acetonitrile
proved to be unsuitable; in the reductive electrochemical
detection mode, trace levels of oxygen, present in the
sample, show a chromatographic behaviour similar to
that ofadriamycin. A methanol 0"02 M phosphate buffer
(pH 4’2) (40:60 w/w) mobile phase and a LiChrosorb
RP-8 column proved to solve this problem. This mobile
phase permits the separation ofadriamycin and adriamy-
cinol and shows sufficient retention with respect to
oxygen.
In batchwise experiments using the static mercury drop
electrode (SMDE), adriamycin and adriamycinol show
an adsorption ’pre-peak’ and a reduction peak in the
cathodic (forward) scan and one oxidation peak in the
anodic (backward) scan. The peak potentials in the
cathodic and anodic scans of adriamycin and adriamyci-
nol are -588 and -440 mV (n 4, SD 2 mV) and
-547 and -440 mV (n 3, SD 3 mV), respectively.
As the peak potentials of the two compounds differ only
slightly, separation techniques are needed for differenti-
ation, in both stock solutions and biological samples.
In HPLC with cyclic voltammetric detection using the
same electrodes and the same scan speed, both com-
pounds show one reduction peak in the forward scan and
one oxidation peak in the backward scan; the peak
potentials of the cathodic and anodic scans ofadriamycin
and adriamycinol are -583 and -440 mV (n 5, SD
3 mV) and -538 and -440 mV (n 3, SD 3 mV),
respectively.
Analysis of the urine extract demonstrate that both
adriamycin and adriamycinol are detectable in the
reductive cyclic voltammetric mode. Adriamycin shows
one reduction peak (figure 4a), but probably the concen-
tration of adriamycinol in the urine is too low to form a
well defined peak in the cathodic scan (figure 4b).
11oH. H. J. L. Ploegmakers et al. Computerized cyclic voltammetric detection after HPLC
+5000
/4000
=+3000
/2000
+1000
^-1000
-4000
0 -200 -400 -600 -800 -1000
(a/ Potantlol Ag/AgCI (3M KCI)
+5000
,.,/4000
/3000
/2000
-1000
-513013
0 -200 -400 -600 -800 1000
(b) Pot=ntlol Ag/AgCl (3M KCl)
Figure 4. On-line reductive cyclic voltammogram of(a) adriamycin
and (b) adriamycinol in a urine extract after HPLC separation
Conditions: 100 tl injected," current range, 50 nA full-scale;
flow-rate, 2 ml/min; scan speed, 300 m V/s; mobile phase,
methanol- 0"02 M phosphate buffer (pH 4"2) (40:60 w/w);
column, LiChrosorb RP-8.
The peak potentials ofthe forward and backward scans of
adriamycin are -529 and -438 mV (n 5, SD 4 mV),
respectively, whereas the peak potential in the forward
scan of adriamycinol is -520 mV.
The on-line experiments described above show substan-
tial differences in the observed cathodic peak potentials of
adriamycin (-583 and -529 mV) when analysing the
pure compound and a urine extract at different concen-
trations. In the anodic scans, however, the peak poten-
tials are the same and the peak heights are almost
identical. Probably this phenomenon is caused by
adsorption. Analyses for adriamycin and adriamycinol
are always hampered (or even supported) by strong
adsorption, e.g., on a glass surface [21], mercury
electrodes [30] or carbon paste electrodes [31]. The
theory and practical applications of the influence of
adsorption on cyclic voltammetric curves have been
described by Wopschall and Shain [32-34]. However, the
adsorption of adriamycin is complex and the lack of
correlation between the theory and the experimental
results is not yet understood. At concentrations where
adsorption itself becomes important, only qualitative
comparisons can be made with theory [33], but a
semi-empirical method has been developed which
appears to be generally applicable [34]. However, the
described method permits the application of extra
parameters to investigate adriamycin compared with
batch-wise voltammetry, such as flowing systems and
time dependence. The adsorption behaviour might be of
importance in understanding its behaviour in vivo.
Conclusions
For qualitative analysis in particular, the computerized
cyclic voltammetric detection system after HPLC de-
scribed here has several promising properties compared
with previously described amperometric systems at
constant potential [11-14]. The ultimate sensitivity for
the analysis of biological samples has not yet been
reached and needs to be optimized. As the.system is
provided with an oxidative and reductive module, all
kinds of electroactive compounds can be investigated.
The cyclic voltammetric system described has been
applied to the identification ofetoposide and teniposide in
urine samples using the oxidative mode and adriamycin
and adriamycinol using the reductive mode.
In a previous study [1] we calculated the ’half-wave
potentials’ of etoposide and teniposide, using the same
electrodes in the same system. However, the ’half-wave
potentials’ of these two compounds calculated here have
more positive values. Probably this difference is caused
by the decreased reactivity of the (same) GCE after 2
years ofintensive use. As glassy carbon is known not to be
a homogeneous and defined material like mercury, the
application of a new electrode will show a different
reactivity. Therefore, batch-wise and on-line cyclic vol-
tammetry need to be performed at the same time with the
same GCE for optimum comparisons. In the reductive
cyclic voltammetric mode, the calculated peak potentials
in the cathodic scan for adriamycin present in a stock
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solution and a urine extract differ by 54 mV, whereas the
peak potentials in the anodic scan are identical; the
anodic peaks are higher than the cathodic peaks. These
results are probably caused by adsorption effects, which
differ in flowing and unstirred solutions.
The model compounds were selected to show that the
described methods could substantially yield more infor-
mation than existing methods. In the future, special
attention will be paid to sensitivity. Methods are being
developed, based on the method described here, for
investigating the relationship between pH and the
electrochemical properties of anticancer drugs both in
vitro and in vivo.
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